Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies

被引:56
作者
Chakravarty, Soumya D. [1 ]
Yee, Arthur F.
Paget, Stephen A.
机构
[1] Cornell Univ, Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA
关键词
CD203C; PATHOGENESIS; ACTIVATION; MARKER;
D O I
10.1016/j.jaci.2011.08.023
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1354 / 1355
页数:3
相关论文
共 12 条
[1]   Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria [J].
Arkwright, Peter D. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) :510-511
[2]   Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients [J].
Binder, M ;
Fierlbeck, G ;
King, TP ;
Valent, P ;
Bühring, HJ .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 129 (02) :160-168
[3]   The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis [J].
Bühring, HJ ;
Streble, A ;
Valent, P .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 133 (04) :317-329
[4]   Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria [J].
Grattan, CEH ;
O'Donnell, BF ;
Francis, DM ;
Niimi, N ;
Barlow, RJ ;
Seed, PT ;
Black, AK ;
Greaves, MW .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (02) :365-372
[5]   THE PATHOGENESIS OF CHRONIC IDIOPATHIC URTICARIA - NEW EVIDENCE SUGGESTS AN AUTOIMMUNE BASIS AND IMPLICATIONS FOR TREATMENT [J].
HIDE, M ;
FRANCIS, DM ;
GRATTAN, CEH ;
BARR, RM ;
WINKELMANN, RK ;
GREAVES, MW .
CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (07) :624-627
[6]   Pathogenesis of chronic urticaria [J].
Kaplan, A. P. ;
Greaves, M. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (06) :777-787
[7]   Treatment of chronic autoimmune urticaria with omalizumab [J].
Kaplan, Allen P. ;
Joseph, Kusumam ;
Maykut, Robert J. ;
Geba, Gregory P. ;
Zeldin, Robert K. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :569-573
[8]   Lack of response of severe steroid-dependent chronic urticaria to rituximab [J].
Mallipeddi, R. ;
Grattan, C. E. H. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (03) :333-334
[9]   Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase [J].
Maurer, Marcus ;
Altrichter, Sabine ;
Bieber, Thomas ;
Biedermann, Tilo ;
Braeutigam, Matthias ;
Seyfried, Stefan ;
Brehler, Randolf ;
Grabbe, Juergen ;
Hunzelmann, Nicolas ;
Jakob, Thilo ;
Jung, Andreas ;
Kleine-Tebbe, Joerg ;
Mempel, Martin ;
Meurer, Michael ;
Reich, Kristian ;
Rueff, Franziska ;
Schaekel, Knut ;
Sengupta, Kaushik ;
Sieder, Christian ;
Simon, Jan C. ;
Wedi, Bettina ;
Zuberbier, Torsten ;
Mahler, Vera ;
Staubach, Petra .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (01) :202-U326
[10]   LYMPHOCYTE SUBPOPULATIONS IN THE SKIN OF PATIENTS WITH CHRONIC URTICARIA [J].
MEKORI, YA ;
GIORNO, RC ;
ANDERSON, P ;
KOHLER, PF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1983, 72 (06) :681-684